Determining the appropriate retatrutide regimen is absolutely necessary for achieving desired outcomes . Initially, patients typically start with a introductory quantity of approximately 2.4 mg, given once week via subcutaneous . This starting quantity is then gradually increased every four periods, up to a highest dose of 10.8 mg, based on indivi